marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Verrica Pharmaceuticals Financial Statements 2011-2024 | VRCA
Annual Financial Statements Verrica Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
245 M | 252 M | 227 M | 294 M | 363 M | 176 M | - | - | - | - | - | - | - |
Shares |
45.3 M | 34.2 M | 27 M | 25 M | 24.9 M | 14.7 M | - | - | - | - | - | - | - |
Historical Prices |
5.41 | 7.39 | 8.38 | 13.7 | 11.9 | 11.3 | - | - | - | - | - | - | - |
Net Income |
-67 M | -24.5 M | -35.1 M | -42.7 M | -28.2 M | -20.6 M | -4.46 M | -1.91 M | - | - | - | - | - |
Revenue |
5.12 M | 9.03 M | 12 M | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
500 K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-65.8 M | -21.3 M | -30.9 M | -40.2 M | -30.1 M | -21.9 M | -4.46 M | - | - | - | - | - | - |
Interest Expense |
3.96 M | 2.17 M | 4.3 M | 3.03 M | - | - | - | - | - | - | - | - | - |
EBITDA |
-65.2 M | -20.8 M | -30.7 M | -40 M | -29.8 M | -21.9 M | -4.46 M | -1.91 M | - | - | - | - | - |
Operating Expenses |
70.9 M | 30.3 M | 42.9 M | 40.2 M | 30.1 M | 21.9 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
47.3 M | 17.4 M | 27 M | 24.5 M | 14.6 M | 9.05 M | 727 K | 204 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Verrica Pharmaceuticals
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
46.5 M | 46.5 M | 42.4 M | 46.1 M | 45.9 M | 43 M | 41.1 M | 40.3 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 27.5 M | 25.6 M | 25.4 M | 25 M | 25 M | 25 M | 24.9 M | 24.9 M | 24.9 M | 24.9 M | 24.8 M | 24.8 M | 5.75 M | 2.85 M | 2.85 M | 2.85 M | 2.85 M | 2.85 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-17.2 M | -20.3 M | - | -24.8 M | -11 M | -6.59 M | - | 83 K | -10.2 M | -8.47 M | - | -12.8 M | -11.8 M | -936 K | - | -10.5 M | -9.41 M | -9.82 M | -7.64 M | -6.09 M | -7 M | -7.48 M | -7.58 M | -5.91 M | -5.32 M | -1.85 M | -1.44 M | -1.36 M | -1.1 M | -570 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
5.18 M | 3.83 M | - | 2.92 M | 182 K | 37 K | - | 8.32 M | 214 K | 431 K | - | - | - | 12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
700 K | 700 K | - | 300 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-15.2 M | -18.6 M | - | -23.9 M | -11.6 M | -7.09 M | - | 1.45 M | -9.12 M | -7.41 M | - | -11.8 M | -10.7 M | 60 K | - | -9.64 M | -8.63 M | -9.88 M | -7.99 M | -6.54 M | -7.52 M | -8.03 M | -8.19 M | -6.33 M | -5.47 M | -1.89 M | -1.43 M | -1.36 M | -1.1 M | -570 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
2.37 M | 2.32 M | - | 1.66 M | - | - | - | 81 K | 1.07 M | 1.08 M | - | 1.09 M | 1.08 M | 1.03 M | - | 918 K | 904 K | 220 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-15.1 M | -18.5 M | - | - | -11.5 M | -6.96 M | - | 1.77 M | -8.92 M | -7.31 M | - | -11.7 M | -10.7 M | 71 K | - | -9.61 M | -8.6 M | -9.87 M | -7.99 M | -6.5 M | -7.5 M | -8.02 M | -8.19 M | -6.32 M | -5.46 M | -1.89 M | -1.43 M | -1.36 M | -1.1 M | -570 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
20.4 M | 22.4 M | - | 26.8 M | 11.8 M | 7.13 M | - | 6.87 M | 9.34 M | 7.84 M | - | 11.8 M | 10.7 M | 11.9 M | - | 9.64 M | 8.63 M | 9.88 M | 7.99 M | 6.54 M | 7.52 M | 8.03 M | 8.19 M | 6.33 M | 5.47 M | 1.89 M | 1.43 M | 1.36 M | 1.1 M | 570 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
16.5 M | 16.3 M | - | 20.1 M | 5.94 M | 4.32 M | - | 3.92 M | 5.17 M | 5.12 M | - | 8 M | 7.28 M | 6.58 M | - | 4.65 M | 5.11 M | 4.99 M | 4.02 M | 3.49 M | 3.59 M | 3.54 M | 3.27 M | 2.86 M | 1.96 M | 961 K | 316 K | 238 K | 118 K | 55 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency